(1->4)-beta-D-glucan multiple interactions ISO RGD:731622 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VCP mRNA CTD PMID:36331819 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of VCP protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:731622 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of VCP mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:731622 6480464 1, 2-Dimethylhydrazine results in increased expression of VCP mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:731621 6480464 Dinitrochlorobenzene binds to VCP protein CTD PMID:32991956 17alpha-ethynylestradiol increases expression ISO RGD:731622 6480464 Ethinyl Estradiol results in increased expression of VCP mRNA CTD PMID:17555576 , PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:731622 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VCP mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:731621 6480464 Estradiol results in decreased expression of VCP mRNA CTD PMID:23373633 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:731621 6480464 Metribolone promotes the reaction [NDRG1 protein binds to VCP protein] CTD PMID:17220478 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:731621 6480464 Metribolone results in increased expression of VCP protein CTD PMID:17152098 1H-pyrazole increases expression ISO RGD:731622 6480464 pyrazole results in increased expression of VCP mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731622 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VCP mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731622 6480464 Tetrachlorodibenzodioxin affects the expression of VCP mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VCP mRNA, Tetrachlorodibenzodioxin results in increased expression of VCP protein CTD PMID:19201780 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VCP protein CTD PMID:16548065 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:731622 6480464 2 more ... CTD PMID:18550172 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of VCP mRNA CTD PMID:21346803 4,4'-sulfonyldiphenol increases expression ISO RGD:731621 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of VCP protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO RGD:731622 6480464 Fenretinide results in increased expression of VCP mRNA CTD PMID:28973697 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of VCP protein] CTD PMID:30980806 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22248470 aflatoxin B1 increases methylation ISO RGD:731621 6480464 Aflatoxin B1 results in increased methylation of VCP intron CTD PMID:30157460 aristolochic acid A decreases expression ISO RGD:731621 6480464 aristolochic acid I results in decreased expression of VCP mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of VCP protein CTD PMID:21791222 arsenous acid multiple interactions ISO RGD:731621 6480464 Arsenic Trioxide promotes the reaction [CREBBP protein results in increased expression of VCP mRNA] CTD PMID:18822310 atrazine decreases expression ISO RGD:731621 6480464 Atrazine results in decreased expression of VCP mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:731622 6480464 Benzo(a)pyrene results in increased expression of VCP mRNA CTD PMID:21715664 benzo[a]pyrene multiple interactions ISO RGD:731621 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased expression of VCP protein modified form CTD PMID:24464499 bisphenol A increases expression ISO RGD:731622 6480464 bisphenol A results in increased expression of VCP mRNA, bisphenol A results in increased expression of VCP protein CTD PMID:21932408 , PMID:28279065 bisphenol A decreases expression ISO RGD:731622 6480464 bisphenol A results in decreased expression of VCP protein CTD PMID:35999755 bisphenol A decreases expression ISO RGD:731621 6480464 bisphenol A results in decreased expression of VCP protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:731621 6480464 bisphenol A results in increased expression of VCP protein CTD PMID:33670352 bisphenol A decreases methylation ISO RGD:731621 6480464 bisphenol A results in decreased methylation of VCP promoter CTD PMID:30352284 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VCP mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:731621 6480464 bisphenol B results in increased expression of VCP protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:731621 6480464 bisphenol F results in increased expression of VCP protein CTD PMID:34186270 bortezomib increases expression ISO RGD:731621 6480464 Bortezomib results in increased expression of VCP mRNA CTD PMID:20977926 cadmium atom multiple interactions ISO RGD:731621 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VCP protein CTD PMID:33040242 cadmium dichloride affects localization ISO RGD:731621 6480464 Cadmium Chloride affects the localization of VCP protein CTD PMID:18261755 cadmium dichloride multiple interactions ISO RGD:731621 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VCP protein CTD PMID:33040242 cadmium dichloride decreases expression ISO RGD:731621 6480464 Cadmium Chloride results in decreased expression of VCP protein CTD PMID:24419708 cadmium dichloride affects localization EXP 6480464 Cadmium Chloride affects the localization of VCP protein CTD PMID:18261755 cadmium dichloride affects localization ISO RGD:731622 6480464 Cadmium Chloride affects the localization of VCP protein CTD PMID:18261755 caffeine decreases expression ISO RGD:731621 6480464 Caffeine results in decreased expression of VCP protein CTD PMID:31195006 caffeine increases phosphorylation ISO RGD:731621 6480464 Caffeine results in increased phosphorylation of VCP protein CTD PMID:35688186 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of VCP mRNA CTD PMID:17293106 ceruletide decreases expression EXP 6480464 Ceruletide results in decreased expression of VCP protein CTD PMID:18024178 chenodeoxycholic acid multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 chloropicrin increases expression ISO RGD:731621 6480464 chloropicrin results in increased expression of VCP mRNA CTD PMID:26352163 chloroquine multiple interactions ISO RGD:731621 6480464 Chloroquine promotes the reaction [VCP protein mutant form results in increased expression of TARDBP protein] CTD PMID:25884947 chloroquine multiple interactions ISO RGD:731622 6480464 Chloroquine inhibits the reaction [VCP protein mutant form results in decreased expression of MAP1LC3B protein], Chloroquine inhibits the reaction [VCP protein mutant form results in increased expression of OPTN protein] CTD PMID:25884947 chromium trinitrate decreases expression ISO RGD:731622 6480464 chromium nitrate results in decreased expression of VCP protein CTD PMID:22144121 copper(II) sulfate increases expression ISO RGD:731621 6480464 Copper Sulfate results in increased expression of VCP mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:731621 6480464 Asbestos, Crocidolite results in increased expression of VCP protein CTD PMID:29553831 cyclosporin A decreases methylation ISO RGD:731621 6480464 Cyclosporine results in decreased methylation of VCP promoter CTD PMID:27989131 cyclosporin A multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 deoxycholic acid multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 diarsenic trioxide multiple interactions ISO RGD:731621 6480464 Arsenic Trioxide promotes the reaction [CREBBP protein results in increased expression of VCP mRNA] CTD PMID:18822310 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of VCP mRNA CTD PMID:18636392 diethylstilbestrol decreases expression ISO RGD:731622 6480464 Diethylstilbestrol results in decreased expression of VCP mRNA CTD PMID:22467019 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of VCP mRNA, Endosulfan results in increased expression of VCP protein CTD PMID:31464424 enzyme inhibitor multiple interactions ISO RGD:731621 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of VCP protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:731622 6480464 epoxiconazole results in decreased expression of VCP mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of VCP protein CTD PMID:23702218 ethanol multiple interactions ISO RGD:731622 6480464 Ethanol affects the expression of and affects the splicing of VCP mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:731622 6480464 Fenthion results in decreased expression of VCP mRNA CTD PMID:34813904 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of VCP protein CTD PMID:33656234 finasteride increases expression EXP 6480464 Finasteride results in increased expression of VCP mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of VCP mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:731622 6480464 Folic Acid results in decreased expression of VCP mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:731622 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of VCP mRNA] CTD PMID:22206623 glycochenodeoxycholic acid multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:731621 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of VCP mRNA CTD PMID:32152650 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of VCP protein] CTD PMID:23178681 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of VCP protein CTD PMID:15370871 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of VCP protein] CTD PMID:23178681 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of VCP protein CTD PMID:23178681 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 ivermectin decreases expression ISO RGD:731621 6480464 Ivermectin results in decreased expression of VCP protein CTD PMID:32959892 L-serine decreases expression ISO RGD:731621 6480464 Serine results in decreased expression of VCP mRNA CTD PMID:29098664 lactacystin multiple interactions ISO RGD:731621 6480464 lactacystin promotes the reaction [VCP protein binds to UBXN1 protein binds to PSMD4 protein] CTD PMID:15362974 lactacystin increases expression ISO RGD:731621 6480464 lactacystin results in increased expression of VCP protein CTD PMID:15362974 lead(II) chloride decreases expression ISO RGD:731621 6480464 lead chloride results in decreased expression of VCP protein CTD PMID:24419708 leflunomide decreases expression ISO RGD:731621 6480464 leflunomide results in decreased expression of VCP mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:731621 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of VCP mRNA CTD PMID:35877022 lovastatin decreases expression ISO RGD:731622 6480464 Lovastatin results in decreased expression of VCP mRNA CTD PMID:20493250 lovastatin increases expression ISO RGD:731622 6480464 Lovastatin results in increased expression of VCP mRNA CTD PMID:20493250 lycopene increases expression ISO RGD:731621 6480464 lycopene results in increased expression of VCP mRNA CTD PMID:16886892 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:731621 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of VCP protein CTD PMID:15362974 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:731621 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [VCP protein binds to UBXN1 protein binds to PSMD4 protein] CTD PMID:15362974 naphthalene affects binding ISO RGD:731622 6480464 naphthalene metabolite binds to VCP protein CTD PMID:16206326 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of VCP mRNA CTD PMID:24136188 ochratoxin A increases expression ISO RGD:731622 6480464 ochratoxin A results in increased expression of VCP protein CTD PMID:19445961 okadaic acid decreases expression ISO RGD:731621 6480464 Okadaic Acid results in decreased expression of VCP mRNA CTD PMID:28939011 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of VCP mRNA CTD PMID:18636392 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of VCP protein CTD PMID:16538041 paracetamol affects expression ISO RGD:731622 6480464 Acetaminophen affects the expression of VCP mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid affects expression ISO RGD:731622 6480464 perfluorooctane sulfonic acid affects the expression of VCP mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:731622 6480464 perfluorooctane sulfonic acid results in increased expression of VCP mRNA CTD PMID:20936131 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731622 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VCP mRNA, PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of VCP mRNA] CTD PMID:20936131 , PMID:36331819 perfluorooctanoic acid affects expression ISO RGD:731622 6480464 perfluorooctanoic acid affects the expression of VCP mRNA CTD PMID:19429403 phenethyl isothiocyanate affects binding ISO RGD:731621 6480464 VCP protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of VCP mRNA CTD PMID:19162173 piroxicam decreases expression ISO RGD:731621 6480464 Piroxicam results in decreased expression of VCP mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:731622 6480464 potassium chromate(VI) results in decreased expression of VCP protein CTD PMID:22144121 potassium chromate affects response to substance ISO RGD:731621 6480464 VCP mRNA affects the susceptibility to potassium chromate(VI) CTD PMID:22144121 prostaglandin A1 increases metabolic processing ISO RGD:731622 6480464 prostaglandin A1 analog results in increased metabolism of VCP protein CTD PMID:19800325 quartz affects expression ISO RGD:731621 6480464 Quartz affects the expression of VCP protein CTD PMID:27917503 quercetin decreases phosphorylation ISO RGD:731621 6480464 Quercetin results in decreased phosphorylation of VCP protein CTD PMID:35688186 resveratrol multiple interactions ISO RGD:731621 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of VCP mRNA CTD PMID:23557933 rotenone increases oxidation EXP 6480464 Rotenone results in increased oxidation of VCP protein CTD PMID:30951809 rotenone decreases expression ISO RGD:731621 6480464 Rotenone results in decreased expression of VCP mRNA CTD PMID:29955902 silicon dioxide affects secretion ISO RGD:731621 6480464 Silicon Dioxide analog affects the secretion of VCP protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:731621 6480464 Silicon Dioxide results in increased expression of VCP mRNA CTD PMID:25351596 silicon dioxide affects expression ISO RGD:731621 6480464 Silicon Dioxide affects the expression of VCP protein CTD PMID:27917503 sirolimus multiple interactions ISO RGD:731621 6480464 Sirolimus inhibits the reaction [VCP protein mutant form results in increased expression of SQSTM1 protein] CTD PMID:25884947 sirolimus multiple interactions ISO RGD:731622 6480464 Sirolimus inhibits the reaction [VCP protein mutant form results in decreased expression of MAP1LC3B protein] more ... CTD PMID:25884947 sodium arsenite decreases expression ISO RGD:731621 6480464 sodium arsenite results in decreased expression of VCP protein CTD PMID:21925251 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of VCP protein CTD PMID:31874112 sodium arsenite increases expression ISO RGD:731621 6480464 sodium arsenite results in increased expression of VCP mRNA, sodium arsenite results in increased expression of VCP protein CTD PMID:15362974 , PMID:20886546 sodium dichromate increases expression ISO RGD:731622 6480464 sodium bichromate results in increased expression of VCP mRNA CTD PMID:22155349 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of VCP mRNA CTD PMID:22561333 streptozocin multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of VCP protein] CTD PMID:30980806 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of VCP protein CTD PMID:30980806 sulforaphane affects binding ISO RGD:731621 6480464 VCP protein binds to sulforaphane CTD PMID:21838287 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of VCP mRNA CTD PMID:24136188 sunitinib decreases expression ISO RGD:731621 6480464 Sunitinib results in decreased expression of VCP mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:731622 6480464 Tamoxifen affects the expression of VCP mRNA CTD PMID:17555576 taurine decreases expression ISO RGD:731621 6480464 Taurine results in decreased expression of VCP mRNA CTD PMID:16579726 temozolomide increases expression ISO RGD:731621 6480464 Temozolomide results in increased expression of VCP mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO RGD:731621 6480464 testosterone enanthate affects the expression of VCP mRNA CTD PMID:17440010 tetrachloromethane multiple interactions EXP 6480464 [Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of VCP protein CTD PMID:25303780 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of VCP protein CTD PMID:35544339 thimerosal decreases expression ISO RGD:731621 6480464 Thimerosal results in decreased expression of VCP mRNA CTD PMID:27188386 trichloroethene affects expression ISO RGD:731622 6480464 Trichloroethylene affects the expression of VCP mRNA CTD PMID:21135412 trimellitic anhydride increases expression ISO RGD:731622 6480464 trimellitic anhydride results in increased expression of VCP mRNA CTD PMID:19042947 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of VCP mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:731621 6480464 Valproic Acid results in decreased methylation of VCP gene CTD PMID:29154799 valproic acid affects expression ISO RGD:731621 6480464 Valproic Acid affects the expression of VCP mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of VCP mRNA CTD PMID:23034163 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of VCP gene CTD PMID:31682807 vorinostat increases expression ISO RGD:731621 6480464 vorinostat results in increased expression of VCP protein CTD PMID:20543569 warfarin decreases expression ISO RGD:731622 6480464 Warfarin results in decreased expression of VCP mRNA CTD PMID:20493250 warfarin increases expression ISO RGD:731622 6480464 Warfarin results in increased expression of VCP mRNA CTD PMID:20493250